Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma.

about

Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP.Soluble TACI and soluble BCMA as biomarkers in primary central nervous system lymphoma.

P2860

Q41434494-E42D69A8-9DFB-48B9-AA02-3DB537EAA416 Q50638113-CD1A9AC3-6E71-4AAC-9C57-AAA3754B39B0

P2860

Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma.

Item

http://www.wikidata.org/entity/Q40957585

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Expression of B-cell activatin ...... ntral nervous system lymphoma.

@en

type

Item

label

Expression of B-cell activatin ...... ntral nervous system lymphoma.

@en

prefLabel

Expression of B-cell activatin ...... ntral nervous system lymphoma.

@en

P1476

Expression of B-cell activatin ...... ntral nervous system lymphoma.

@en

P2093

Andreas Straube

http://www.w3.org/2001/XMLSchema#string

Louisa von Baumgarten

http://www.w3.org/2001/XMLSchema#string

Sigrid Langer

http://www.w3.org/2001/XMLSchema#string

Sigrun Roeber

http://www.w3.org/2001/XMLSchema#string

Tobias Birnbaum

http://www.w3.org/2001/XMLSchema#string

P2860

BAFF is produced by astrocytes and up-regulated in multiple sclerosis lesions and primary central nervous system lymphoma

APRIL is overexpressed in cancer: link with tumor progression

The rGel/BLyS fusion toxin inhibits diffuse large B-cell lymphoma growth in vitro and in vivo.

The role of the BAFF/APRIL system in B cell homeostasis and lymphoid cancers.

Pathogenesis and management of primary CNS lymphoma.

Development and characterization of APRIL antagonistic monoclonal antibodies for treatment of B-cell lymphomas.

Mutations of CARD11 but not TNFAIP3 may activate the NF-kappaB pathway in primary CNS lymphoma.

Tumor targeting of vincristine by mBAFF-modified PEG liposomes in B lymphoma cells.

Expression of BAFF-R and TACI in reactive lymphoid tissues and B-cell lymphomas.

Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcome.

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4081/NI.2013.E4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236959870

http://www.w3.org/2001/XMLSchema#string

P698

23717783

http://www.w3.org/2001/XMLSchema#string

P932

3661982

http://www.w3.org/2001/XMLSchema#string

Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma.

about

P2860

P2860

Expression of B-cell activating factor, a proliferating inducing ligand and its receptors in primary central nervous system lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P932